Nordea Investment Management Ab Biomarin Pharmaceutical Inc Transaction History

Nordea Investment Management Ab

$85.8 Billion
Q3 2024

A detailed history of Nordea Investment Management Ab transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Nordea Investment Management Ab holds 14,822 shares of BMRN stock, worth $940,011. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,822

Previous 14,852 0.2%

Holding current value

$940,011

Previous $1.22 Million 14.81%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$69.02 - $93.84 $2,070 - $2,815	-30 Reduced 0.2%	14,822 $1.04 Million
Q2 2024 Aug 08, 2024	BUY	$74.43 - $92.22 $87,604 - $108,542	1,177 Added 8.61%	14,852 $1.22 Million
Q1 2024 May 02, 2024	BUY	$83.81 - $99.0 $174,408 - $206,019	2,081 Added 17.95%	13,675 $1.19 Million
Q4 2023 Jan 10, 2024	BUY	$76.22 - $98.51 $41,463 - $53,589	544 Added 4.92%	11,594 $1.12 Million
Q3 2023 Nov 13, 2023	SELL	$85.07 - $94.48 $44,321 - $49,224	-521 Reduced 4.5%	11,050 $977,000
Q3 2022 Oct 19, 2022	BUY	$82.16 - $96.94 $47,734 - $56,322	581 Added 5.29%	11,571 $996,000
Q2 2022 Aug 09, 2022	BUY	$71.48 - $86.85 $168,835 - $205,139	2,362 Added 27.38%	10,990 $906,000
Q3 2021 Nov 01, 2021	SELL	$74.77 - $85.47 $645,115 - $737,435	-8,628 Reduced 50.0%	8,628 $666,000
Q3 2021 Nov 01, 2021	BUY	$74.77 - $85.47 $645,115 - $737,435	8,628 Added 100.0%	17,256 $1.33 Million
Q4 2020 Feb 12, 2021	BUY	$72.61 - $90.2 $68,834 - $85,509	948 Added 12.34%	8,628 $757,000
Q3 2020 Nov 09, 2020	SELL	$71.87 - $131.03 $551,961 - $1.01 Million	-7,680 Reduced 50.0%	7,680 $590,000
Q2 2020 Aug 13, 2020	BUY	$79.55 - $124.22 $610,944 - $954,009	7,680 Added 100.0%	15,360 $1.89 Million
Q1 2020 May 15, 2020	BUY	$71.37 - $96.85 $27,334 - $37,093	383 Added 5.25%	7,680 $634,000
Q3 2019 Nov 13, 2019	BUY	$67.4 - $85.11 $44,281 - $55,917	657 Added 9.89%	7,297 $497,000
Q2 2019 Aug 14, 2019	SELL	$80.35 - $93.9 $42,183 - $49,297	-525 Reduced 7.33%	6,640 $569,000
Q1 2019 May 20, 2019	SELL	$84.2 - $98.62 $3,452 - $4,043	-41 Reduced 0.57%	7,165 $637,000
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $13,806 - $15,540	147 Added 2.08%	7,206 $699,000
Q2 2018 Aug 13, 2018	SELL	$76.01 - $99.03 $4.35 Million - $5.66 Million	-57,190 Reduced 89.01%	7,059 $665,000
Q1 2018 May 14, 2018	SELL	$77.67 - $92.63 $983,302 - $1.17 Million	-12,660 Reduced 16.46%	64,249 $5.21 Million
Q4 2017 Feb 12, 2018	SELL	$80.76 - $95.13 $1.71 Million - $2.01 Million	-21,130 Reduced 21.55%	76,909 $6.86 Million
Q3 2017 Nov 09, 2017	BUY	$80.6 - $94.95 $7.9 Million - $9.31 Million	98,039	98,039 $9.12 Million

Others Institutions Holding BMRN

# of Institutions

635

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.

Account

Nordea Investment Management Ab Biomarin Pharmaceutical Inc Transaction History